phospho-raf1 Search Results


93
ABclonal Biotechnology p raf1
SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of <t>AKT/eNOS/ERK/Raf1/p38</t> expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor
P Raf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf1-S338+Rabbit+pAb/pmc12106210-98-64-68
Average 93 stars, based on 1 article reviews
p raf1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems r d systems pps060
SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of <t>AKT/eNOS/ERK/Raf1/p38</t> expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor
R D Systems Pps060, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf-1+(S301)+Antibody/bio_rxiv__64898__2026__01__07__698161-45-27-27
Average 94 stars, based on 1 article reviews
r d systems pps060 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Boster Bio anti p mlkl
SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of <t>AKT/eNOS/ERK/Raf1/p38</t> expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor
Anti P Mlkl, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Anti-Phospho-MLKL+(S345)+Rabbit+Monoclonal+Antibody/pm41862445-182-144-145
Average 92 stars, based on 1 article reviews
anti p mlkl - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Stressgen Biotechnologies immunoaffinity purified rabbit polyclonal antibody to raf-1
SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of <t>AKT/eNOS/ERK/Raf1/p38</t> expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor
Immunoaffinity Purified Rabbit Polyclonal Antibody To Raf 1, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/phospho+raf+1+antibody/pm17064357-51-23-27
Average 90 stars, based on 1 article reviews
immunoaffinity purified rabbit polyclonal antibody to raf-1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co phospho-raf1
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Phospho Raf1, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/raf1/pmc05772059-403-88-99
Average 90 stars, based on 1 article reviews
phospho-raf1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
NSJ Bioreagents phospho-raf1 antibody / c-raf
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Phospho Raf1 Antibody / C Raf, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf1+Antibody+%2F+c-Raf/custom%40rq5030%4023922489
Average 90 stars, based on 1 article reviews
phospho-raf1 antibody / c-raf - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Genecopoeia phospho-raf1-s259 rabbit mab
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Phospho Raf1 S259 Rabbit Mab, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf1-S259+Rabbit+mAb/custom%40mab-02469%4032698890
Average 95 stars, based on 1 article reviews
phospho-raf1-s259 rabbit mab - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Genecopoeia phospho-raf1-s621 rabbit mab
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Phospho Raf1 S621 Rabbit Mab, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf1-S621+Rabbit+mAb/custom%40mab-02468%4032698890
Average 95 stars, based on 1 article reviews
phospho-raf1-s621 rabbit mab - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
ABclonal Biotechnology antibodies for akt
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Antibodies For Akt, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-Raf1-S259+Rabbit+mAb/pm41166762-213-0-12
Average 93 stars, based on 1 article reviews
antibodies for akt - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
ABclonal Biotechnology rabbit phospho braf antibody
a Expression level of PP5 (left) and <t>phospho-Raf1</t> S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test
Rabbit Phospho Braf Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-raf1/Phospho-BRAF-S445+Rabbit+pAb/pm34902510-52-30-34
Average 90 stars, based on 1 article reviews
rabbit phospho braf antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier



Image Search Results


SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of AKT/eNOS/ERK/Raf1/p38 expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: LncRNA SNHG15 promotes angiogenesis and improves cardiac repair after myocardial infarction through MiR-665-mediated KDR expression

doi: 10.1007/s00018-025-05737-2

Figure Lengend Snippet: SNHG15 regulates HCAECs proliferation, migration, and tube formation by upregulating KDR. ( A) , Efficiency of knocking down and overexpressing SNHG15 by RT-qPCR, n = 3. ( B) , Representative and quantitative KDR protein levels in HCAECs after the knockdown and overexpression of SNHG15 by Western blotting detection, n = 3. ( C) , Representative and quantification of AKT/eNOS/ERK/Raf1/p38 expressions and phosphorylation in HCAECs treated with the knockdown and overexpression of SNHG15 following western blotting detection, n = 3. ( D and E ), Cell proliferation was measured through EdU staining and quantification of EdU-positive cells at 6 h after the knockdown and overexpression of SNHG15. Scale bar = 20 μm, n = 3. ( F and G ), Migration ability was measured by the transwell assay and quantification of transwell cells at 24 h after the knockdown and overexpression of SNHG15. Scale bar = 200 μm, n = 3. ( H and I) , Migration ability was measured through wound healing assays and migration rate quantification at the indicated time points. Scale bar = 200 μm, n = 3. ( J and K ), The angiogenic response was measured by conducting tube formation assay and quantification analysis of the total tube length and tube branches number. Scale bar = 50 μm, n = 3. * P < 0.05 versus siRNA ctrl group; P < 0.05 versus SNHG15 OE ctrl group. Data is the mean ± SEM. Two-way ANOVA with Bonferroni multiple comparisons test ( B , C , E , G , I , K ). HCAECs, human coronary artery endothelial cells; KDR, kinase domain-containing receptor

Article Snippet: Membranes were blocked with 5% skim milk for 1 h at 37 °C before incubated with primary antibodies against KDR (Cat. No. 26415-1-AP, Proteintech), AKT (Cat. No. 10176-2-AP, Proteintech), eNOS (Cat. No. A20985, Abclonal), ERK (Cat. No. A4782, Abclonal), Raf1 (Cat. No. A19638, Abclonal), p38 (Cat. No. A14401, Abclonal), p-AKT (Cat. No. 66444-1-lg, Proteintech), p-eNOS (Cat. No. AP1404, Abclonal), p-ERK (Cat. No. AP0974, Abclonal), p-Raf1 (Cat. No. AP0498, Abclonal), and p- p38 (Cat. No. AP0526, Abclonal), followed by at 4 °C for overnight.

Techniques: Migration, Quantitative RT-PCR, Knockdown, Over Expression, Western Blot, Phospho-proteomics, Staining, Transwell Assay, Tube Formation Assay

SNHG15 in ECs promotes therapeutic angiogenesis to against cardiac remodeling and dysfunction post-MI. ( A ), Schematic diagram depicting the time course of MI-induced cardiac remodeling and dysfunction in mice receiving AAV-SNHG15 or AAV-Scr. ( B ), Kaplan–Meier survival analysis of mice treated with sham ( n = 8), MI ( n = 22), MI + AAV- Scr ( n = 23) and MI-AAV-SNHG15 ( n = 23) post-MI. ( C and D ), Echocardiography and measured LVEF, FS, LVEDD and LVSDD in mice, n = 6. ( E and F ), Hematoxylin-eosin staining, Masson’s trichrome, and quantification of cardiac fibrosis, n = 6. ( G) , Representative and quantitative of KDR protein levels in the ECs of infarct border zone after MI through western blot detection, n = 6. ( H) , Representative and quantification of AKT/eNOS/ERK/Raf1/p38 expressions and phosphorylation in the border zone were analyzed using western blotting, n = 6. ( I and J ), Representative images and quantification of immunofluorescence staining for CD31 + /Ki67 + cells in the border zone of infarcted hearts at 7 days post-MI. Scale bar = 20 μm, n = 6. ( K and L) , Representative images and quantification of immunofluorescence staining for CD31 + cells in the border zone of infarcted hearts at 28 days post-MI. Scale bar = 20 μm, n = 6. Data are the mean ± SEM. HRF, high resolution field. The survival rate was analyzed by Kaplan-Meier method and compared by log-rank test ( B ). Two-way ANOVA with Bonferroni multiple comparisons test ( D , F , G , H , J , L ). ECs, endothelial cells; MI, myocardial infarction; LVEDD, Left ventricular end-diastolic diameter; LVESD, Left ventricular end-systolic diameter; LVEF, Left ventricular ejection fraction; FS, fractional shortening; KDR, kinase domain-containing receptor; Scr, scramble

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: LncRNA SNHG15 promotes angiogenesis and improves cardiac repair after myocardial infarction through MiR-665-mediated KDR expression

doi: 10.1007/s00018-025-05737-2

Figure Lengend Snippet: SNHG15 in ECs promotes therapeutic angiogenesis to against cardiac remodeling and dysfunction post-MI. ( A ), Schematic diagram depicting the time course of MI-induced cardiac remodeling and dysfunction in mice receiving AAV-SNHG15 or AAV-Scr. ( B ), Kaplan–Meier survival analysis of mice treated with sham ( n = 8), MI ( n = 22), MI + AAV- Scr ( n = 23) and MI-AAV-SNHG15 ( n = 23) post-MI. ( C and D ), Echocardiography and measured LVEF, FS, LVEDD and LVSDD in mice, n = 6. ( E and F ), Hematoxylin-eosin staining, Masson’s trichrome, and quantification of cardiac fibrosis, n = 6. ( G) , Representative and quantitative of KDR protein levels in the ECs of infarct border zone after MI through western blot detection, n = 6. ( H) , Representative and quantification of AKT/eNOS/ERK/Raf1/p38 expressions and phosphorylation in the border zone were analyzed using western blotting, n = 6. ( I and J ), Representative images and quantification of immunofluorescence staining for CD31 + /Ki67 + cells in the border zone of infarcted hearts at 7 days post-MI. Scale bar = 20 μm, n = 6. ( K and L) , Representative images and quantification of immunofluorescence staining for CD31 + cells in the border zone of infarcted hearts at 28 days post-MI. Scale bar = 20 μm, n = 6. Data are the mean ± SEM. HRF, high resolution field. The survival rate was analyzed by Kaplan-Meier method and compared by log-rank test ( B ). Two-way ANOVA with Bonferroni multiple comparisons test ( D , F , G , H , J , L ). ECs, endothelial cells; MI, myocardial infarction; LVEDD, Left ventricular end-diastolic diameter; LVESD, Left ventricular end-systolic diameter; LVEF, Left ventricular ejection fraction; FS, fractional shortening; KDR, kinase domain-containing receptor; Scr, scramble

Article Snippet: Membranes were blocked with 5% skim milk for 1 h at 37 °C before incubated with primary antibodies against KDR (Cat. No. 26415-1-AP, Proteintech), AKT (Cat. No. 10176-2-AP, Proteintech), eNOS (Cat. No. A20985, Abclonal), ERK (Cat. No. A4782, Abclonal), Raf1 (Cat. No. A19638, Abclonal), p38 (Cat. No. A14401, Abclonal), p-AKT (Cat. No. 66444-1-lg, Proteintech), p-eNOS (Cat. No. AP1404, Abclonal), p-ERK (Cat. No. AP0974, Abclonal), p-Raf1 (Cat. No. AP0498, Abclonal), and p- p38 (Cat. No. AP0526, Abclonal), followed by at 4 °C for overnight.

Techniques: Staining, Western Blot, Phospho-proteomics, Immunofluorescence

a Expression level of PP5 (left) and phospho-Raf1 S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test

Journal: Nature Communications

Article Title: Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes

doi: 10.1038/s41467-017-02483-3

Figure Lengend Snippet: a Expression level of PP5 (left) and phospho-Raf1 S338 (right) in PP5 TG vs. WT mouse hearts by western blot. mean ± s.e.m., n = 4 hearts/group (age 5–6 months); duplicate analysis/group. b Sarcomeric localization of PP5 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm. Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. c PP5 localization in cardiomyocytes from PP5 TG and WT mouse hearts by indirect immunofluorescence. PP5 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK (titin) antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). d PP5 overexpression specifically decreases titin phosphorylation at N2Bus in PP5 TG vs. WT hearts. Total titin phosphorylation measured by ProQ Diamond/Sypro Ruby staining (upper left), site-specific titin phosphorylation detected by western blot using antibodies to P-S3991, P-S4043, P-S4080 (all N2Bus; right panels), P-S2080 (titin Z/I junction), and P-S12742 (PEVK region). Phospho-titin signals were normalized to total titin signals detected by WB using a panel of sequence-specific antibodies (Pan). Means were indexed to those of control (WT) groups. Data are mean ± s.e.m., n = 4 hearts/group, samples analyzed in triplicate. e Localization of phospho-N2Bus P-S3991 in cardiomyocytes from PP5 TG and WT hearts by indirect immunofluorescence. Anti-N2Bus P-S3991 antibody (secondary antibody: Cy3-conjugated IgG), counterstained with anti-PEVK antibody (secondary antibody: FITC-conjugated IgG). Bars, 2 µm (main) and 1 µm (insets). f Sarcomeric localization of phospho-N2Bus P-S3991 in PP5 WT and TG hearts by immunogold electron microscopy. Bars, 500 nm (main) and 100 nm (insets). Bar graph shows average number of gold particles counted in 50-µm 2 -sized regions-of-interest (ROI), either on the sarcomeric I-band or elsewhere in the cardiomyocyte (‘Not on I-band’). Data are mean ± s.e.m., n = 5 ROIs from 2 hearts/group. In a and d , bar graphs show relative signal changes indexed to the respective controls. In a , b , d , and f , * p < 0.05 and *** p < 0.001, by two-tailed Student’s t -test

Article Snippet: Antibodies to the following proteins were used: PP5 (target, N-terminal of human PP5; Cell Signaling, #2289; polyclonal, rabbit; 1:2000), PP5c (target, rat PP5 amino acids 36–238; 3/PP5; BD Biosciences, 611021; monoclonal, mouse; 1:2000), GAPDH (target, full-length protein corresponding to human GAPDH; Abcam, #ab9484; monoclonal, mouse; 1:2000), PP1α (target, peptide corresponding to the N-terminal sequence of human PP1α; Cell Signaling, #2582; polyclonal, rabbit; 1:1000), PP2a (α + β isoform; target, peptide corresponding to amino acids at the C-terminus of human PP2A catalytic subunit; Cell Signaling, #2038; polyclonal, rabbit; 1:1000), phospho-Raf1 (Ser338; target, phosphopeptide corresponding to residues 333–345 of human Raf-1; Merck, 05–538; monoclonal, mouse; 1:1000), Hsp90 (target, peptide surrounding Asn300 of human Hsp90; C45G5; Cell Signaling, #4877S; monoclonal, rabbit; 1:1000), ERK1/2 (target, peptide corresponding to a sequence in the C-terminus of rat p44 MAP kinase; Cell Signaling, #9102; polyclonal, rabbit; 1:1000) and phospho-ERK1/2 (target, phosphopeptide corresponding to residues surrounding Thr 202 /Tyr 204 of ERK/MAPK; Biaffin, #AB-pERK-100; polyclonal, rabbit; 1:1000).

Techniques: Expressing, Western Blot, Electron Microscopy, Immunofluorescence, Over Expression, Staining, Sequencing, Two Tailed Test

Under basal conditions, PP5 activity towards titin N2Bus and MAPK/ERK family member Raf1 is low and the relatively high distensibility of N2Bus results in relatively low titin-based passive tension (left side). The strain-dependent mechanosensor connecting MAPKs to N2Bus via FHL-1 functions normally, as downstream signaling from Raf1 to ERK2 is enabled. When PP5 expression is increased (as in failing hearts) and PP5 becomes activated through interaction with Hsp90, Ca 2+ /S100 protein, arachidonic acid (aa), or long chain fatty acid-CoA esters (LCACE), the phosphatase translocates to the I-band mechanosensor at N2Bus (right side). Thus, N2Bus (previously phosphorylated by ERK2, PKA, PKG, or CaMKII) is dephosphorylated, which reduces its distensibility and increases titin-based passive tension; the mechanosensor is now less sensitive. Raf-1 is also dephosphorylated and signaling to ERK2 is disabled, such that the mechanosensor function is additionally compromised. The process is embedded in signaling pathways activated via G-protein coupled receptor (GPCR) and Ras, and it can be reversed when PP5 is deactivated. (Molecules that have a color code were studied here, those with no color/white background were inferred from the literature)

Journal: Nature Communications

Article Title: Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes

doi: 10.1038/s41467-017-02483-3

Figure Lengend Snippet: Under basal conditions, PP5 activity towards titin N2Bus and MAPK/ERK family member Raf1 is low and the relatively high distensibility of N2Bus results in relatively low titin-based passive tension (left side). The strain-dependent mechanosensor connecting MAPKs to N2Bus via FHL-1 functions normally, as downstream signaling from Raf1 to ERK2 is enabled. When PP5 expression is increased (as in failing hearts) and PP5 becomes activated through interaction with Hsp90, Ca 2+ /S100 protein, arachidonic acid (aa), or long chain fatty acid-CoA esters (LCACE), the phosphatase translocates to the I-band mechanosensor at N2Bus (right side). Thus, N2Bus (previously phosphorylated by ERK2, PKA, PKG, or CaMKII) is dephosphorylated, which reduces its distensibility and increases titin-based passive tension; the mechanosensor is now less sensitive. Raf-1 is also dephosphorylated and signaling to ERK2 is disabled, such that the mechanosensor function is additionally compromised. The process is embedded in signaling pathways activated via G-protein coupled receptor (GPCR) and Ras, and it can be reversed when PP5 is deactivated. (Molecules that have a color code were studied here, those with no color/white background were inferred from the literature)

Article Snippet: Antibodies to the following proteins were used: PP5 (target, N-terminal of human PP5; Cell Signaling, #2289; polyclonal, rabbit; 1:2000), PP5c (target, rat PP5 amino acids 36–238; 3/PP5; BD Biosciences, 611021; monoclonal, mouse; 1:2000), GAPDH (target, full-length protein corresponding to human GAPDH; Abcam, #ab9484; monoclonal, mouse; 1:2000), PP1α (target, peptide corresponding to the N-terminal sequence of human PP1α; Cell Signaling, #2582; polyclonal, rabbit; 1:1000), PP2a (α + β isoform; target, peptide corresponding to amino acids at the C-terminus of human PP2A catalytic subunit; Cell Signaling, #2038; polyclonal, rabbit; 1:1000), phospho-Raf1 (Ser338; target, phosphopeptide corresponding to residues 333–345 of human Raf-1; Merck, 05–538; monoclonal, mouse; 1:1000), Hsp90 (target, peptide surrounding Asn300 of human Hsp90; C45G5; Cell Signaling, #4877S; monoclonal, rabbit; 1:1000), ERK1/2 (target, peptide corresponding to a sequence in the C-terminus of rat p44 MAP kinase; Cell Signaling, #9102; polyclonal, rabbit; 1:1000) and phospho-ERK1/2 (target, phosphopeptide corresponding to residues surrounding Thr 202 /Tyr 204 of ERK/MAPK; Biaffin, #AB-pERK-100; polyclonal, rabbit; 1:1000).

Techniques: Activity Assay, Expressing